AVITA MEDICAL News & Analysis

Mark LaMonica, CFA hosts Adrian Atkins (Senior Equity Analyst - covering utilities, transports and REITs including AGL Energy and Transurban) and...

Analysts say the incident has given the medical device company a 'rare opportunity’ to expand its market share.

Covid's winners and losers are returning to their prior trajectories. 

A return to normal has increased the incidence of burns and that means business for the spray-on-skin maker.

The single-product company is high-risk, high-reward.

Morningstar is looking past the reported net loss to increased use of the company’s flagship spray-on skin therapy.

The company’s revolutionary RECELL system is set to become a standard treatment and boost market share, says Nicolette Quinn.

There are 14 names under Morningstar coverage and some have defensive qualities

The corona sell-off hurt the spray-on-skin maker but it’s got an eye on the bigger picture, says Nicolette Quinn

The corona sell-off has unearthed discounts among makers of gloves, pharmaceutical goods and spray-on skin technology.